MELVIN GONZALEZ

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PALM SPRINGS, CA NPI 1194721167

General Payments — all program years on this page

$13,768.69

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 260
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $274.74 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $274.7413

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $8,987.5711
2019 $925.0840
2020 $630.0434
2021 $1,013.5971
2022 $803.4838
2023 $1,134.1953
2024 $274.7413

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077935586 Janssen Pharmaceuticals, Inc $17.34 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077935646 Janssen Pharmaceuticals, Inc $14.36 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886501 Novartis Pharmaceuticals Corporation $16.92 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886503 Novartis Pharmaceuticals Corporation $13.97 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886505 Novartis Pharmaceuticals Corporation $27.14 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886511 Novartis Pharmaceuticals Corporation $21.50 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886513 Novartis Pharmaceuticals Corporation $20.61 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886515 Novartis Pharmaceuticals Corporation $21.48 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086886521 Novartis Pharmaceuticals Corporation $31.98 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097321259 Novo Nordisk Inc $25.00 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097812179 Novo Nordisk Inc $19.61 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101333174 E.R. Squibb & Sons, L.L.C. $24.81 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132863375 ATRICURE, INC. $20.02 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.